182 related articles for article (PubMed ID: 30024495)
1. Clinical significance of matrix metalloproteinase-2 in endometrial cancer: A systematic review and meta-analysis.
Liu C; Li Y; Hu S; Chen Y; Gao L; Liu D; Guo H; Yang Y
Medicine (Baltimore); 2018 Jul; 97(29):e10994. PubMed ID: 30024495
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
[TBL] [Abstract][Full Text] [Related]
3. Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions.
Graesslin O; Cortez A; Uzan C; Birembaut P; Quereux C; Daraï E
Int J Gynecol Cancer; 2006; 16(5):1911-7. PubMed ID: 17009991
[TBL] [Abstract][Full Text] [Related]
4. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H
Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221
[TBL] [Abstract][Full Text] [Related]
5. Pathological and prognostic significance of matrix metalloproteinase-2 expression in ovarian cancer: a meta-analysis.
Liu C
Clin Exp Med; 2016 Aug; 16(3):375-82. PubMed ID: 26123901
[TBL] [Abstract][Full Text] [Related]
6. Expression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma.
Karahan N; Güney M; Baspinar S; Oral B; Kapucuoglu N; Mungan T
Eur J Gynaecol Oncol; 2007; 28(3):184-8. PubMed ID: 17624083
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of MMP-9 overexpression in endometrial cancer: A PRISMA-compliant meta-analysis.
Li X; Zha L; Li B; Sun R; Liu J; Zeng H
Front Oncol; 2022; 12():925424. PubMed ID: 36387161
[TBL] [Abstract][Full Text] [Related]
8. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
[TBL] [Abstract][Full Text] [Related]
9. ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer.
Monge M; Colas E; Doll A; Gonzalez M; Gil-Moreno A; Planaguma J; Quiles M; Arbos MA; Garcia A; Castellvi J; Llaurado M; Rigau M; Alazzouzi H; Xercavins J; Alameda F; Reventos J; Abal M
Cancer Res; 2007 Jul; 67(14):6753-9. PubMed ID: 17638886
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
[TBL] [Abstract][Full Text] [Related]
11. [Expression of matrix metalloproteinase-2, 9 and it's tissue inhibitor-1, 2 in endometrial carcinoma].
Guo W; Chen G; Zhu C; Wang H
Zhonghua Fu Chan Ke Za Zhi; 2002 Oct; 37(10):604-7. PubMed ID: 12487935
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase (MMP)-2 and MMP-9 expression in tumor infiltrating CD3 lymphocytes from women with endometrial cancer.
Jedryka M; Chrobak A; Chelmonska-Soyta A; Gawron D; Halbersztadt A; Wojnar A; Kornafel J
Int J Gynecol Cancer; 2012 Oct; 22(8):1303-9. PubMed ID: 22964525
[TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of Twist1 and MMP-2 in endometrial endometrioid adenocarcinoma].
Wang XJ; Chen XH
Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):588-91. PubMed ID: 23158991
[TBL] [Abstract][Full Text] [Related]
14. The prognostic role of matrix metalloproteinase 2 in gastric cancer: a systematic review with meta-analysis.
Shen W; Xi H; Wei B; Chen L
J Cancer Res Clin Oncol; 2014 Jun; 140(6):1003-9. PubMed ID: 24610446
[TBL] [Abstract][Full Text] [Related]
15. Changes in the Extracellular Matrix in Endometrial and Cervical Cancer: A Systematic Review.
Padežnik T; Oleksy A; Cokan A; Takač I; Sobočan M
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982551
[TBL] [Abstract][Full Text] [Related]
16. Lipocalin-2 and matrix metalloproteinase-9 expression in high-grade endometrial cancer and their prognostic value.
Srdelić Mihalj S; Kuzmić-Prusac I; Zekić-Tomaš S; Šamija-Projić I; Čapkun V
Histopathology; 2015 Aug; 67(2):206-15. PubMed ID: 25522256
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitory effect on estrogen production and its influence on invasive ability of human endometrial cells of endometriosis by medicated serum of SLW].
Li A; Wang Y; Dong W; Xu X
Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(12):1607-11. PubMed ID: 20815218
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of special AT-rich sequence-binding protein 1 in endometrial cancer: a clinicopathologic study.
Zhang Y; Wang L; Liu Y; Meng F; Wang S; Shang P; Gao Y; Chen X
Int J Gynecol Cancer; 2015 Jan; 25(1):4-11. PubMed ID: 25347096
[TBL] [Abstract][Full Text] [Related]
20. Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma.
Han JC; Li XD; Du J; Xu F; Wei YJ; Li HB; Zhang YJ
World J Surg Oncol; 2015 Jan; 13():5. PubMed ID: 25588786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
